CLINICAL
PHARMACOLOGY OF DRUGS USED IN HEART FAILURE
The
American College of Cardiology/American Heart Association (ACC/AHA) guidelines
for management of chronic heart failure specify four stages in the development
of heart failure (Table 13–3). Patients in stage A are at high risk because of
other disease but have no signs or symptoms of heart failure. Stage B patients
have evidence of structural heart disease but no symptoms of heart failure.
Stage C patients have structural heart disease and symp-toms of failure, and
symptoms are responsive to ordinary therapy. Stage D patients have heart
failure refractory to ordinary therapy, and special interventions
(resynchronization therapy, transplant) are required.
Once
stage C is reached, the severity of heart failure is usually described
according to a scale devised by the New York Heart Association. Class I failure
is associated with no limitations on ordinary activities, and symptoms that
occur only with greater than ordinary exercise. Class II is characterized by
slight limitation of activities, and results in fatigue and palpitations with
ordinary physical activity. Class III failure results in no symptoms at rest,
but fatigue, shortness of breath, and tachycardia occur with less than ordinary
physical activity. Class IV is associated with symp-toms even when the patient
is at rest.
Related Topics
Privacy Policy, Terms and Conditions, DMCA Policy and Compliant
Copyright © 2018-2024 BrainKart.com; All Rights Reserved. Developed by Therithal info, Chennai.